002872 ST天聖製藥
按盤價 
5.570 +0.110 (+2.015%)
5.570 +0.110 (+2.015%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -2.286 | -4.267 | -4.355 | -4.065 | -2.939 |
| 總資產報酬率 ROA (%) | -1.684 | -3.151 | -3.220 | -2.974 | -2.004 |
| 投入資產回報率 ROIC (%) | -1.883 | -3.574 | -3.701 | -3.376 | -2.320 | 邊際利潤分析 |
| 銷售毛利率 (%) | 48.240 | 47.652 | 47.083 | 56.574 | 41.264 |
| 營業利潤率 (%) | -13.466 | -16.505 | -16.152 | -13.955 | -8.279 |
| 息稅前利潤/營業總收入 (%) | -11.803 | -16.092 | -15.196 | -12.495 | -6.170 |
| 淨利潤/營業總收入 (%) | -13.122 | -15.472 | -16.176 | -15.083 | -9.820 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 142.273 | 73.922 | 101.621 | 125.389 | 141.257 |
| 價值變動淨收益/利潤總額(%) | -3.498 | -16.938 | -2.123 | -5.850 | -8.395 |
| 營業外收支淨額/利潤總額(%) | 0.192 | 3.843 | 1.214 | -0.701 | -12.026 | 償債能力分析 |
| 流動比率 (X) | 2.014 | 1.955 | 1.520 | 1.469 | 1.947 |
| 速動比率 (X) | 1.688 | 1.658 | 1.221 | 1.234 | 1.684 |
| 資產負債率 (%) | 25.639 | 26.380 | 25.445 | 26.360 | 26.948 |
| 帶息債務/全部投入資本 (%) | 12.131 | 10.473 | 6.826 | 7.155 | 11.136 |
| 股東權益/帶息債務 (%) | 677.119 | 788.791 | 1,244.126 | 1,188.356 | 729.639 |
| 股東權益/負債合計 (%) | 288.826 | 277.872 | 292.414 | 278.749 | 270.393 |
| 利息保障倍數 (X) | -6.989 | -15.000 | -13.169 | -9.164 | -5.053 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 87.447 | 84.235 | 90.600 | 92.643 | 182.129 |
| 存貨周轉天數 (天) | 162.438 | 146.673 | 156.822 | 174.443 | 171.872 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 14/11/2025 14:13 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
